Product Images Ifosfamide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Ifosfamide NDC 0143-9531 by Hikma Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structural Formula - ifosfamide injection 1

Structural Formula - ifosfamide injection 1

Vial label for Ifosfamide Injection 1 g/20 mL - ifosfamide injection 2

Vial label for Ifosfamide Injection 1 g/20 mL - ifosfamide injection 2

This is a description of a pharmaceutical product. The product is called Ifosfamide, and it is available in an injectable form for intravenous use. Each vial contains 50mg of Ifosfamide and is a cytotoxic agent used to treat cancer. The dosage and administration details are not available from the text.*

Vial label for Ifosfamide Injection 3 g/60 mL - ifosfamide injection 3

Vial label for Ifosfamide Injection 3 g/60 mL - ifosfamide injection 3

IFOSFAMIDE %255 INJECTION is a prescription medication used as a Gytotoxic Agent. It contains monobasic sodium phosphate, phosphates monobasic monohydrate, and 1095 mo, with a concentration of 50mg/ml and available in a package of 60 sterile syringes. It should be stored in an effective refrigerator at 2* to 8% at a temperature of 5 to 10 °C. It is used only for intravenous use.*

ifosfamide injection 4

ifosfamide injection 4

This is a product identification label with a GTIN (Global Trade Item Number) of 0301234567896, a SN (Serial Number) of 1234567890123, an expiration date of MMMYYYY, and a LOT (Lot Number) of ABCDE12345.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.